iShares Nasdaq Biotechnology ETF (IBB)
| 131.78 Delayed Data As of 4:36pm ET |  -3.09 / -2.29%Today’s Change | 92.15 Today|||52-Week Range 146.53 | +9.35% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Biotech Bonanza - Second Half Outlook Jul 28 / Seeking Alpha - Paid Partner Content |
Performance
| 1 month | -2.78% | 3 years | +9.05% | |
| 3 months | +7.09% | 5 years | +2.30% | |
| 1 year | +31.31% | Since inception | +7.65% |
Data through 08/08/2020
Quote Details
| Previous close | $134.87 |
| Open day’s range | 131.68 – 134.62 |
| Net asset value (NAV) | 136.24 (08/07/2020) |
| Daily volume | 223,176 |
| Average volume (3 months) | 3,447,480 |
Data as of 4:36pm ET, 08/11/2020
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +2.30% | +6.57% |
| Expense Gross exp ratio | 0.47% | 1.22% |
| Risk 5 year sharpe ratio | 0.13 | 0.37 |
| Net assets | $9.7B | $3.5B |
| Average market cap | $17.1B | $40.8B |
| Average P/E | 24.1 | 27.0 |
| Dividend / Share | -- | 0.28% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
| XHE SPDR® S&P Health Care Equipment ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| AMGN Amgen | 8.50% |
| VRTX Vertex Pharmaceuticals Inc | 7.47% |
| GILD Gilead Sciences | 7.13% |
| REGN Regeneron Pharmaceuticals | 6.75% |
| ILMN Illumina Inc | 5.95% |
| BIIB Biogen | 3.57% |
| MRNA Moderna Inc | 3.12% |
| SGEN Seattle Genetics Inc | 3.12% |
| ALXN Alexion Pharmaceuticals Inc | 2.45% |
| BMRN Biomarin Pharmaceutical Inc | 2.35% |
